Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression

Texto completo
Autor(es):
Zaccarelli-Filho, Carlos Alberto [1] ; Ono, Erika ; Machado, Daisy Maria [3] ; Brunialti, Milena ; Succi, Regina Célia de Menezes ; Salomão, Reinaldo ; Kallás, Esper Georges ; Moraes-Pinto, Maria Isabel de
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Universidade Federal de São Paulo (UNIFESP). Campus São Paulo - Vila Clementino. Escola Paulista de Medicina. Departamento de Medicina - Brasil
[3] Universidade Federal de São Paulo (UNIFESP). Campus São Paulo - Vila Clementino. Escola Paulista de Medicina. Departamento de Medicina - Brasil
Número total de Afiliações: 8
Tipo de documento: Artigo Científico
Fonte: Cytometry Part A; v. 72, n. 1, p. 14-21, Jan. 2007.
Área do conhecimento: Ciências da Saúde - Medicina
Assunto(s):Doenças transmissíveis   Infecções por vírus de RNA   Infecções por HIV   Terapia antirretroviral de alta atividade   Ativação linfocitária
Resumo

HIV-1-infected children show changes of blood lymphocyte subpopulations. We have, therefore, investigated how highly active anti-retroviral therapy (ART) alter these subsets. Blood samples were taken from 41 HIV-1-infected children on ART who were divided into groups showing good, partial and poor responses to ART on the basis of viral load (VL) measurement in blood. The observations were compared to those seen in 20 uninfected children. The samples were studied using 4-color flow cytometry for "naive", central memory and effector memory cells as well as for CD38 expression as the sign of activation within both the CD4+ and the CD8+ T cell populations. HIV-1 infected children were also evaluated for the presence and the titers of antibodies induced by vaccination against childhood infections in our patients while on HAART. Lymphocyte counts were lower in the "poor" viral load responding (VLR) group when compared with partial and good VLRs. Poor VLRs had lower total and naive CD4+ T cell counts. HIV-1-infected children from all three groups had high CD8+ T cell counts. Central memory CD4+ and CD8+ T cell percentages were particularly low in the poor VLR group while in the poor VLR group the percentages of effector memory CD4+ and CD8+ T cells were higher when compared with the control group. Higher cellular activation of CD8+ T cells was observed in HIV-1-infected children, particularly when analyzed for the intensity of CD38 expression in the poor VLR group. CD5 expression on B cells was higher among all HIV-1-infected children. Antibodies to tetanus, diphtheria, measles, rubella, and hepatitis B were present in a large proportion of children but the titers were similarly low for all three groups of HIV-infected children. Children with different levels of viral response to HAART present immune phenotype characteristics that tend to place the children with partial and good virological responses into the same group. These children are still moderately deficient in their immune responses but show better recovery than seen with children in the poor VLR group. These observations indicate that the proportions of central memory cells among the CD4+ T cells and the intensity of the expression of CD38 activation antigen on CD8+ T cells provide more informative parameters for monitoring children on HAART than the absolute numbers of CD4+ and CD8+ T cells alone. (AU)

Processo FAPESP: 01/11012-2 - Comparacao das subpopulacoes e celulas monomorfonucleares em sangue de cordao umbilical de recem nascidos de maes infectadas pelo virus da imunodeficiencia humana tipo 1.
Beneficiário:Carlos Alberto Zaccarelli Filho
Linha de fomento: Bolsas no Brasil - Mestrado
Processo FAPESP: 01/11086-6 - Fatores associados à supressão viral prolongada em crianças infectadas pelo vírus da imunodeficiência humana (HIV-1) em uso de drogas anti-retrovirais
Beneficiário:Daisy Maria Machado
Linha de fomento: Auxílio à Pesquisa - Regular